Adial Pharmaceuticals holds annual shareholder meeting, quorum present

• Adial Pharmaceuticals held its 2026 annual shareholder meeting on Sept. 17, 2026.
• Shareholders adopted an amendment to the 2017 Equity Incentive Plan to raise the share pool available for issuance.
• A new 2026 Equity Incentive Plan was adopted.
• A 2026 Employee Stock Purchase Plan was adopted.
• CBIZ CPAs P.C. was ratified as independent auditor for the year ending Dec. 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-101434), on September 18, 2026, and is solely responsible for the information contained therein.